Resistant Hypertension Course

RHC

Effective control of blood pressure levels in hypertensive patients is associated with a reduction in cardiovascular mortality and in the incidence of stroke, myocardial infarction and renal events. Yet, despite the use of combinations of antihypertensive drugs, blood pressure control cannot be obtained in a consistent proportion of patients. In order to provide resistant hypertensive (“RH”) patients with optimal care, a holistic team approach for the decision-making process and appropriate use of these techniques is crucial.

This first RH Course is a joint initiative of the European Society of Hypertension (ESH), the European Association of Percutaneous Cardiovascular Intervention (EAPCI) and PCR aiming to provide a forum for hypertension specialists, physicians caring for hypertensive patients, physicians performing catheter-based interventional medicine and other healthcare providers to reflect on the current state of knowledge and to share acquired experience.

A Steering Board, whose members work in Hypertension Centers of Excellence, with experience in the field of RH, is proposing this interactive and practical course, an open forum, where concerns can be expressed, answers found and consensus reached.

Our long-term common objectives are to help physicians, across multiple disciplines who are all focused on the resistant hypertensive patient, uncover the answer to “what is the best management and technical strategy for my patient?” and to insure a successful integration of promising new technologies into their armamentarium.

Chairpersons

Sverre Kjeldsen - Norway

 

Felix Mahfoud - Germany

 

Steering board members

Renata Cífková - Czech Republic

 

Pierre-François Plouin - France

 

Roland Schmieder - Germany

 

Download the first announcement